192 results on '"Antmen B"'
Search Results
2. Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement
3. Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis
4. Devastative tongue bleeding due to self-bite after dental extraction in a haemophilia A patient with inhibitor
5. DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE: PH-AB145
6. PHARMACOKINETIC-GUIDED PROPHYLAXIS BASED ON BAYESIAN MODEL WITH MYPKFIT (R) IN HEMOPHILIA A: TURKISH EXPERIENCE
7. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
8. Intracranial hemorrhage in hereditary bleeding disorders: the experience of Çukurova University Hemophilia Center: PO 163
9. The effect of water exercise on atrophic muscles associated with limited range of motion in severe haemophilia A patients: PO 100
10. Iliopsoas hemorrhage in congenital factor deficiencies: the experience of Çukurova University, Adana, Turkey: PO 099
11. Cytokine Levels in Serum of Patients with Juvenile Rheumatoid Arthritis
12. Circumcision Experience in Severe Hemophilia Patients with Inhibitors: PO-WE-135
13. Acquired hemophilia A and the knowledge/awareness level of Turkish hematology fellows: On behalf of the Turkish Hematology Association, Acquired Hemophilia Working Group: PO-TU-086
14. Circumcision and complications in patients with haemophilia in southern part of Turkey: Çukurova experience
15. Session T3.6 Physical and perceptional oral health status of children with hemophilia A: 11FP10
16. PRO45 NATIONAL BURDEN OF HEMOPHILIA A IN TURKEY
17. The value of early treatment in patients with haemophilia and inhibitors
18. A single center experience in Turkey in the molecular diagnosis of Hemophilia B
19. Pharmacokinetic-guided prophylaxis based on bayesian model with myPKFiT (R) in hemophilia A: Turkish experience
20. The use of port-a-cath in children with hemophilia in Cukurova region
21. Deferasirox in children with transfusion-dependent thalassemia or sickle
22. Management of refractory intracranial hemorrhage in a coagulopathic patient with liver disease by using Recombinant Factor Factor VIIa: 32 PO 982
23. Management of refractory hemorrhage in a kala-azar patient with thrombocytopenia and coagulopathy by using Recombinant Factor FACTOR VIIa (rFVIIa): 32 PO 981
24. A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision
25. Circumcision in patients with hemophilia and the other bleeding disorders in southern part of Turkey
26. The surgeries in hemophilia A patients with inhibitors
27. The prophylaxis and the treatment of hepatic veno-occlusive disease after pediatric hematopoetic stem cell transplantation: our single-centre experience
28. Haploidentical stem cell transplantation in children; a single center experience of alpha beta T-cell depleted and unmanipulated transplantation with post-transplant cyclophosphamide
29. Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a single-center experience
30. Clinical Presentation and Management of Factor X Deficiency: Case Study
31. Rare Congenital Bleeding Disorder; Factor VII Deficiencieny And Experience Of Bleeding Treatments: Case Series Of Cukurova University, Adana, Turkey
32. Hematopoietic stem cell transplantation in children with thalassemia major: the experience of single center
33. Oral mucormycosis in children with leukemia: report of 2 cases.
34. Experiences with Use of Port-a-Cath in Children with Hemophilia: Single Center Study
35. Posterior reversible encephalopathy syndrome following pediatric allogeneic bone marrow transplantation: a case series and review
36. BK virus infections in patients with undergoing allogeneic hematopoietic stem cell transplantation
37. Iliopsoas Hemorrhage in Children with Congenital Factor Deficiencies (CFD): Experience from Two Centers in Turkey
38. THE 12 MONTHS FOLLOW-UP RESULTS FROM A COHORT OF PEDIATRIC PATIENTS WITH HEMOGLOBINOPATHY AND USING ORAL IRON CHELATOR FOR TRANSFUSIONAL HEMOSIDEROSIS IN TURKEY
39. A COHORT STUDY TO ASSESS THE CONTRIBUTION OF PATIENT COMPLIANCE PROGRAM ON PERSISTENCE TO DEFERASIROX IN PATIENTS WITH CHRONIC IRON OVERLOAD IN TURKEY (EX-PAT PROGRAM)
40. Busulfan pharmacokinetics in Turkish children who underwent hematopoetic stem cell transplantation
41. Busulfan pharmacokinetics in Turkish children who underwent hematopoetic stem cell transplantation
42. Clinical presentation and management of rare factor deficiencies: case study
43. OUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: RESULTS OF 3-YEAR FOLLOW-UP STUDY
44. The usage of recombinant activated factor VII (RFVIIA) during major and minor surgeries in severe hemophilia patients with inhibitor
45. CIRCUMCISION AND COMPLICATIONS IN ADOLESCENT AND ADULT PATIENTS WIITH HEMOPHILIA IN SOUTHERN PART OF TURKEY
46. MICROPARTICLE PROFILE DURING PAINFUL CRISIS AND NON-CRISIS PERIOD IN SICKLE CELL ANEMIA
47. National pediatric hematopoietic stem cell transplantation activity in Turkey
48. Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients: A randomised, active-controlled, double-blind study
49. OP-02 - The prophylaxis and the treatment of hepatic veno-occlusive disease after pediatric hematopoetic stem cell transplantation: our single-centre experience
50. OUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: 24-MONTH FOLLOW-UP
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.